Company / Book Value per Share
Veracyte, Inc. Book Value per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Book Value per Share
$16.839
FY2025
5-year range
$14.51 / $18.84
FY2021-FY2025
Trend
+4.9%
vs FY2024
Sector context
#70 of 158
Health Care
What the data says
At $16.839, Veracyte, Inc.'s book value per share ranks #70 of 158 in the Health Care sector. Book Value per Share has fluctuated over the past 10 years, ranging from $1.494 in FY2016 to $18.84 in FY2021.
Based on SEC 10-K filings.
$16.839 in FY2025 with a 5-year CAGR of +60.0%.
Improved from $14.51 to $16.839 over the past 2 years.
Health Care sector context is included.
Book Value per Share over time
Growth rates
- 3-Year CAGR
- +3.7%
- 5-Year CAGR
- +60.0%
- 10-Year CAGR
- -
Sector benchmark
#70 of 158 in Health CareTop 44% of 158This company $16.839 Sector average $48.175
▼
-65.0% below sector average
Key checks
Key Insights
- 5-year CAGR of +60.0%, indicating consistent growth.
- In FY2025, book value per share increased 4.9% year-over-year.
- Ranks #70 out of 158 companies in the Health Care sector.
- Peak book value per share was recorded in FY2021.
Company context
Key Data Points
- Altman Z-Score 6.19 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $16.839 | +4.9% |
| FY2024 | $16.051 | +10.6% |
| FY2023 | $14.51 | -4.0% |
| FY2022 | $15.117 | -19.8% |
| FY2021 | $18.84 | +1072.3% |
| FY2020 | $1.607 | -72.6% |
| FY2019 | $5.86 | +148.1% |
| FY2018 | $2.362 | +55.6% |
| FY2017 | $1.518 | +1.6% |
| FY2016 | $1.494 | -34.3% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026